Compare McKesson Corporation (MCK) vs SMX Security Matters plc (SMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs SMX Security Matters plc — how do they compare? McKesson Corporation trades at $884.1 (market cap $105.14B), while SMX Security Matters plc trades at $16.4 (market cap $17.04M). The key difference: McKesson Corporation is far larger — about 6170.2× SMX Security Matters plc's market cap, and McKesson Corporation pays a 0.42% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| MCK | SMX | |
|---|---|---|
Market Cap | $105.14B | $17.04M |
Sector | Health | Technology |
52-Week High | $995.69 | $103.71K |
52-Week Low | $659.01 | $12.87 |
Enterprise Value | $111.67B | -$14.29M |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $889.01, up 1.04% today, with a bullish technical outlook and strong institutional support. Recent Q1 2027 earnings beat expectations, with EPS of $9.93 versus $9.56, driven by specialty drug growth and oncology performance. Revenue reached $359.05B in 2025, with net income of $3.30B, though margins remain thin. The company raised full-year guidance, reflecting operational momentum.
The stock offers upside to the consensus price target of $990.67, supported by 80% analyst buy ratings. Key risks include reliance on pharmaceutical distribution margins, regulatory pressures, and competitive threats. Earnings consistency and cost discipline are critical for sustaining valuation multiples amid healthcare sector volatility.
SMX trades at $15.77, down 0.19% with a bearish technical signal from moving averages. The company reported significant losses with -$169.18M net income for 2025 and negative ROE of -819.22%, though recent news highlights balance sheet strengthening and commercialization progress in recycled plastics traceability. Cash flow remains dependent on financing activities.
Outlook remains challenged by persistent losses and negative profitability metrics, offset by positioning in the growing recycled plastics verification market. Key risks include execution on commercialization and cash burn. Institutional sentiment appears mixed amid fundamental weakness but potential regulatory tailwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
